GHK-Cu: Copper Peptide Research in Skin, Collagen, and Tissue Remodeling

GHK-Cu is the copper complex of the tripeptide glycyl-L-histidyl-L-lysine — three amino acids with a natural affinity for copper(II) ions. First isolated from human plasma by Loren Pickart in 1973, GHK is found naturally in plasma, saliva, and urine, and its concentration declines substantially with age — a fact that anchors much of the research interest around it. Nearly five decades of published work have examined GHK-Cu in laboratory models of collagen synthesis, wound remodeling, skin biology, and gene expression.

This article summarizes what the published research investigates, the mechanisms researchers focus on, and the practical laboratory considerations for working with the compound. As with everything in our Research Library, this is educational material about a research-use-only compound — nothing here describes or supports human or cosmetic use.

What GHK-Cu Is

Two features define GHK-Cu in the literature:

Copper delivery. Copper is an essential cofactor for enzymes central to tissue structure and defense — lysyl oxidase (collagen and elastin cross-linking), superoxide dismutase (antioxidant defense), and cytochrome c oxidase (cellular energy) among them. GHK binds copper(II) with high affinity, and researchers have long studied the complex as a physiological vehicle for delivering copper to cells in a usable, non-toxic form.

Signaling activity. Independent of copper transport, the tripeptide itself has been reported to act as a signaling molecule. The most striking claims in the modern literature come from gene-expression profiling: Pickart and colleagues, analyzing GHK against the Broad Institute’s Connectivity Map data, reported that the peptide modulates the expression of a large fraction of surveyed human genes — shifting expression in directions the authors characterize as regenerative and protective.

Mechanisms Under Investigation

1. Collagen synthesis and dermal remodeling

The foundational finding is from Maquart and colleagues (1988), who reported that GHK-Cu stimulated collagen synthesis in cultured fibroblasts at remarkably low concentrations. Subsequent work extended this to other extracellular matrix components — glycosaminoglycans, decorin, and small proteoglycans — and to the regulation of matrix metalloproteinases and their inhibitors, positioning GHK-Cu in the literature as a remodeling modulator: influencing both the build-up and controlled breakdown sides of matrix turnover.

2. Wound-model research

Animal wound models have reported accelerated closure, increased vessel formation, and improved matrix organization with GHK-Cu treatment. Angiogenesis appears again here as a shared endpoint with BPC-157 and TB-500 research — three different mechanisms in the literature converging on restored blood supply as the rate-limiter of repair.

3. Hair follicle research

In vitro work, including studies by Pyo and colleagues (2007) on human hair follicles, has reported that copper tripeptide complexes stimulated follicle growth and dermal papilla cell activity in culture — the research basis for the compound’s prominence in cosmetic-adjacent literature.

4. Antioxidant and anti-inflammatory signaling

Studies have examined GHK-Cu’s reported suppression of inflammatory cytokines and oxidative stress markers in cell models, with proposed links to its copper-superoxide dismutase relationship.

Reading the Literature Critically

Applying the same standard as the rest of this library:

  • Authorship concentration. A substantial share of the modern GHK literature — especially the sweeping gene-expression claims — comes from Pickart and close collaborators. The foundational collagen work (Maquart) and the hair-follicle work are independent, but the broadest claims have the thinnest independent replication.
  • In vitro weighting. The gene-profiling results are computational analyses of expression databases, and much of the skin literature is cell-culture work. Animal wound-model data exists; controlled human data is limited and largely confined to cosmetic-formulation studies of variable rigor.
  • Concentration effects. Several studies report biphasic behavior — effects at low concentrations that change or reverse at higher ones — which makes concentration control a genuine variable in experimental design rather than a detail.

Laboratory Considerations

Verification. Copper-peptide complexes add a wrinkle to quality control: identity testing must confirm the peptide sequence, and the characteristic blue color of the complex is not by itself evidence of correct stoichiometry or purity. Every batch of GHK-Cu 50mg supplied by Full Scale Peptides is third-party tested for identity and ≥99% purity, with the batch report published in our COA Library before purchase. See how to read a Certificate of Analysis for a walkthrough.

Form, stability, and reconstitution. GHK-Cu is supplied lyophilized and stored at −20°C, protected from light. The copper complex has handling characteristics distinct from plain peptides — we cover them in detail in our dedicated GHK-Cu stability and reconstitution guide, alongside the general storage and handling best practices. Reconstitution in laboratory settings typically uses bacteriostatic water or sterile solvents per protocol.

Related compounds. GHK-Cu appears in combination research with repair peptides — available together as the GLOW Blend (BPC-157/GHK-Cu/TB-500) — and sits alongside SNAP-8 in our Specialty & Cosmetic research category.

Summary

GHK-Cu’s research identity is double-barreled: a copper-delivery vehicle feeding the enzymes that build and protect tissue, and a signaling tripeptide with reported effects on collagen synthesis, matrix remodeling, and gene expression. The collagen and wound-model literature is mature; the broadest gene-modulation claims deserve the skepticism owed to any finding awaiting wide independent replication. For laboratories working on matrix biology and remodeling, verified identity and correct complex stoichiometry are the starting conditions for data worth having.

Browse GHK-Cu 50mg with its published batch COA, or explore the full catalog of third-party tested research peptides.


Research Use Only. All compounds referenced are intended solely for laboratory research and development purposes. Not for human or veterinary use. This article is educational material and does not describe, encourage, or support any use in humans or animals.

References

  1. Maquart FX, et al. Stimulation of collagen synthesis in fibroblast cultures by the tripeptide-copper complex glycyl-L-histidyl-L-lysine-Cu2+. FEBS Letters, 1988.
  2. Pickart L. The human tri-peptide GHK and tissue remodeling. Journal of Biomaterials Science, Polymer Edition, 2008.
  3. Pickart L, Vasquez-Soltero JM, Margolina A. GHK peptide as a natural modulator of multiple cellular pathways in skin regeneration. BioMed Research International, 2015.
  4. Pickart L, Margolina A. Regenerative and protective actions of the GHK-Cu peptide in the light of the new gene data. International Journal of Molecular Sciences, 2018.
  5. Pyo HK, et al. The effect of tripeptide-copper complex on human hair growth in vitro. Archives of Pharmacal Research, 2007.
Scroll to Top
0